Additionally, an increase in the enzyme activity is linked to a number of lung diseases such as asthma and COPD [7, 8], HDAC8 inhibitors are applied for treatment of asthma through decreasing infiltration of inflammatory cells and content of cytokines in lungs [7, 9]. The gene discussed is HDAC8; the disease is asthma.